Evidence map›Paper›PMID 34560364›Full record

ArticleCancer epidemiology2021

County-level characteristics associated with incidence, late-stage incidence, and mortality from screenable cancers.

Jennifer L Moss, Ming Wang, Menglu Liang, Alain Kameni, Kelsey C Stoltzfus, Tracy Onega

Open access · bronzeAbstract read
In one paragraph

Article in Cancer epidemiology, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 13 papers.

0numbers the graph read from it
0cells of the map it votes in
13citing papers in PubMed
1.3field-weighted citation impact, top 17% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

13 citing papers in PubMed, 21 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Travel burden and bypassing closest site for surgical cancer treatment for urban and rural oncology patients.The Journal of rural health : official journal of the American Rural Health Association and the National Rural Health Care Association · 2025
    Article
  6. Review
  7. Article
  8. Article
  9. Tools to Measure the Impact of Structural Racism and Discrimination on Gastrointestinal and Hepatology Disease Outcomes: A Scoping Review.Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association · 2023
    Article
  10. Article
  11. Article
  12. Small-Area Geographic and Socioeconomic Inequalities in Colorectal Cancer in Cyprus.International journal of environmental research and public health · 2022
    Article
  13. Post-Acquisition HyperpolarizedDiagnostics (Basel, Switzerland) · 2022
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 2 institutions in 1 country.

Jennifer L MossPenn State College of Medicine, Hershey, PA, USA. Electronic address: jmoss1@pennstatehealth.psu.edu.
Ming WangPenn State College of Medicine, Hershey, PA, USA.
Menglu LiangPenn State College of Medicine, Hershey, PA, USA.
Alain KameniPenn State College of Medicine, Hershey, PA, USA.
Kelsey C StoltzfusPenn State College of Medicine, Hershey, PA, USA.
Tracy OnegaHuntsman Cancer Institute, Salt Lake City, UT, USA; University of Utah, Salt Lake City, UT, USA.
Penn State Milton S. Hershey Medical Center · USUniversity of Utah · US

Funding

Overcoming barriers to cancer screening among women living in rural and segregated communitiesK22CA225705 · NCI · PENNSYLVANIA STATE UNIV HERSHEY MED CTR · PI MOSS, JENNIFER LINDSAY · 2019 to 2022
$629k
NCI NIH HHS K22 CA225705
6 · The paper itself

Abstract

backgroundCancer screening differs by rurality and racial residential segregation, but the relationship between these county-level characteristics is understudied. Understanding this relationship and its implications for cancer outcomes could inform interventions to decrease cancer disparities.

methodsWe linked county-level information from national data sources: 2008-2012 cancer incidence, late-stage incidence, and mortality rates (for breast, cervical, and colorectal cancer) from U.S. Cancer Statistics and the National Death Index; metropolitan status from U.S. Department of Agriculture; residential segregation derived from American Community Survey; and prevalence of cancer screening from National Cancer Institute's Small Area Estimates. We used multivariable, sparse Poisson generalized linear mixed models to assess cancer incidence, late-stage incidence, and mortality rates by county-level characteristics, controlling for density of physicians and median household income.

resultsCancer incidence, late-stage incidence, and mortality rates were 6-18% lower in metropolitan counties for breast and colorectal cancer, and 2-4% lower in more segregated counties for breast and colorectal cancer. Generally, reductions in cancer associated with residential segregation were limited to non-metropolitan counties. Cancer incidence, late-stage incidence, and mortality rates were associated with screening, with rates for corresponding cancers that were 2-9% higher in areas with more breast and colorectal screening, but 2-15% lower in areas with more cervical screening. DISCUSSION: Lower cancer burden was observed in counties that were metropolitan and more segregated. Effect modification was observed by metropolitan status and county-level residential segregation, indicating that residential segregation may impact healthcare access differently in different county types. Additional studies are needed to inform interventions to reduce county-level disparities in cancer incidence, late-stage incidence, and mortality.

Indexed as

Early Detection of CancerUterine Cervical NeoplasmsFemaleHumansIncidenceMass ScreeningRural PopulationCancer incidenceCancer mortalityCancer screeningMetropolitan statusRacial residential segregation

Identifiers

PMID34560364
PMCPMC8627446
OpenAlexW3200837748

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.